Universal risk assessment upon hospital admission for screening of carriage with multidrug-resistant micro-organisms in a Dutch tertiary care centre.
J Hosp Infect
; 109: 32-39, 2021 Mar.
Article
de En
| MEDLINE
| ID: mdl-33347938
ABSTRACT
BACKGROUND:
In Dutch hospitals a six-point questionnaire is currently mandatory for risk assessment to identify carriers of multidrug-resistant organisms (MDROs) at the time of hospitalization. Presence of one or more risk factors is followed by pre-emptive isolation and microbiological culturing.AIM:
To evaluate the yield of the universal risk assessment in identifying MDRO carriers upon hospitalization.METHODS:
A cross-sectional study was performed using routine healthcare data in a Dutch tertiary hospital between January 1st, 2015 and August 1st, 2019. MDRO risk assessment upon hospitalization included assessment of known MDRO carriage, previous hospitalization in another Dutch hospital during an outbreak or a foreign hospital, living in an asylum centre, exposure to livestock farming, and household membership of a meticillin-resistant Staphylococcus aureus carrier.FINDINGS:
In total, 144,051 admissions of 84,485 unique patients were included; 4480 (3.1%) admissions had a positive MDRO risk assessment. In 1516 (34%) admissions microbiological screening was performed, of which 341 (23%) yielded MDRO. Eighty-one patients were categorized as new MDRO carriers, as identified through MDRO risk assessment, reflecting 0.06% (95% confidence interval 0.04-0.07) of all admissions and 1.8% (1.4-2.2) of those with positive risk assessment. As a result, the number of 'MDRO risk assessments needed to perform' and individual 'MDRO questions needed to ask' to detect one new MDRO carrier upon hospitalization were 1778 and 10,420, respectively.CONCLUSION:
The yield of the current strategy of MDRO risk assessment upon hospitalization is limited and it needs thorough reconsideration.Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
État de porteur sain
/
Dépistage de masse
/
Appréciation des risques
/
Multirésistance bactérienne aux médicaments
/
Staphylococcus aureus résistant à la méticilline
Type d'étude:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limites:
Humans
Pays/Région comme sujet:
Europa
Langue:
En
Journal:
J Hosp Infect
Année:
2021
Type de document:
Article